AKT1 and migraine disorder: A network pharmacology analysis further confirmed the anti-migraine effects of CXCTS were associated with regulating inflammatory response, vasoconstriction, endocrine-neurotransmitter metabolism through PI3K-AKT, HIF-1 and endocrine resistance signalling pathway (Li et al., 2020b).